Natera, Inc. cotiza a 400.71 USD y tiene una capitalización bursátil de $57.8B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.47 | $-0.60 | $0.36 |
| Estimado | $-0.27 | $-0.53 | $-0.55 | $-0.53 |
| Sorpresa | — | +11.3% | -9.1% | +167.9% |
| Métrica | NTRA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -13.4% | -38.6% | +25.2% |
| Net Margin | -9.0% | -33.6% | +24.5% |
| FCF Margin | 4.7% | -13.9% | +18.6% |
| ROE | -12.2% | -40.4% | +28.2% |
| ROA | -8.7% | -32.0% | +23.3% |
| Current Ratio | 3.39 | 2.84 | +0.55 |
| Debt / Equity | — | 0.28 | — |